GIUNTI, ARMANDO
 Distribuzione geografica
Continente #
NA - Nord America 7.573
AS - Asia 5.922
EU - Europa 5.751
SA - Sud America 299
AF - Africa 282
Continente sconosciuto - Info sul continente non disponibili 263
OC - Oceania 5
Totale 20.095
Nazione #
US - Stati Uniti d'America 7.438
CN - Cina 1.913
SG - Singapore 1.597
GB - Regno Unito 1.557
VN - Vietnam 1.128
DE - Germania 863
UA - Ucraina 740
IT - Italia 607
SE - Svezia 587
FR - Francia 408
HK - Hong Kong 404
RU - Federazione Russa 317
IN - India 314
BR - Brasile 199
IE - Irlanda 183
JP - Giappone 156
NL - Olanda 156
KR - Corea 146
ZA - Sudafrica 142
FI - Finlandia 95
CA - Canada 90
EE - Estonia 81
SC - Seychelles 65
BD - Bangladesh 50
JO - Giordania 42
AR - Argentina 40
CH - Svizzera 34
TG - Togo 33
GR - Grecia 22
BE - Belgio 21
PH - Filippine 20
MX - Messico 18
TH - Thailandia 18
CI - Costa d'Avorio 17
CO - Colombia 17
PK - Pakistan 17
BG - Bulgaria 16
EC - Ecuador 16
IQ - Iraq 15
ID - Indonesia 14
SA - Arabia Saudita 13
RO - Romania 12
TR - Turchia 11
TW - Taiwan 11
LB - Libano 10
ES - Italia 8
MY - Malesia 8
PL - Polonia 8
VE - Venezuela 8
CL - Cile 6
CR - Costa Rica 6
MA - Marocco 6
NG - Nigeria 6
AT - Austria 5
AU - Australia 5
CZ - Repubblica Ceca 5
LT - Lituania 5
MD - Moldavia 5
NP - Nepal 5
PE - Perù 5
UZ - Uzbekistan 5
EG - Egitto 4
HN - Honduras 4
IR - Iran 4
JM - Giamaica 4
PR - Porto Rico 4
PS - Palestinian Territory 4
PT - Portogallo 4
PY - Paraguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
HR - Croazia 3
IL - Israele 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
GH - Ghana 2
GT - Guatemala 2
KE - Kenya 2
OM - Oman 2
PA - Panama 2
SY - Repubblica araba siriana 2
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
HT - Haiti 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
ME - Montenegro 1
MG - Madagascar 1
QA - Qatar 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 19.832
Città #
Southend 1.314
Singapore 1.118
Chandler 583
Santa Clara 555
Hefei 546
Jacksonville 529
Ashburn 512
San Jose 448
Fairfield 419
Hong Kong 388
Ann Arbor 371
Council Bluffs 330
Princeton 304
Ho Chi Minh City 280
Wilmington 258
Woodbridge 252
Hanoi 210
Houston 208
Seattle 198
Boardman 192
Beijing 188
Dublin 178
Tokyo 145
Seoul 142
Cambridge 140
Padova 140
Lauterbourg 132
Westminster 132
Nanjing 129
Dong Ket 126
Berlin 122
Los Angeles 114
Helsinki 89
Mülheim 83
Medford 81
Frankfurt am Main 77
Buffalo 73
Milan 68
Mahé 63
Saint Petersburg 62
Jinan 55
Bengaluru 53
Dallas 45
Tianjin 45
Nanchang 44
Amman 42
Ottawa 41
Phoenix 37
Shenyang 37
Shanghai 35
Hebei 34
Lomé 33
Verona 33
Da Nang 30
Changsha 28
San Diego 28
Bern 27
Haiphong 27
Johannesburg 27
Chicago 26
Guangzhou 26
Norwalk 24
Zhengzhou 24
Turin 23
Rome 21
Bologna 20
Brussels 20
Des Moines 20
New York 20
Olalla 20
Redondo Beach 20
Abidjan 17
Haikou 17
Lanzhou 17
Jiaxing 16
Wuhan 16
Xi'an 16
Biên Hòa 15
Kunming 15
San Francisco 15
Hangzhou 14
Sofia 14
Bühl 13
Chengdu 13
London 13
São Paulo 13
Taizhou 13
Dearborn 12
Hải Dương 12
Naples 12
Ningbo 12
Orem 11
Quito 11
Quận Bình Thạnh 11
Yubileyny 11
Baghdad 10
Redwood City 10
Rio de Janeiro 10
Toronto 10
Amsterdam 9
Totale 12.642
Nome #
Realizzazione in vitro in scaffolds compositi e poliuretanici colonizzati con cellule osteoprogenitrici umane isolate da pazienti con patologia ortopedica 257
Valutazione biologica in vitro di nuove molecole bioattive a base di bisfosfonati, sintetizzate mediante strategie catalitiche innovative, per la diagnosi e la terapia di malattie osteolitiche 240
Campi operatori in chirurgia ortopedica 234
In vitro blockade of Receptor Activator of Nuclear factor kappa b ligand prevents osteoclastogenesis induced by neuroblastoma cells 219
Bone-targeted doxorubicin-loaded nanoparticles as a tool for the treatment of skeletal metastases. 219
Alumina and ultra-high molecular weight polyethylene particles differently influence osteoblast-osteoclast interactions 207
Biomimetica di polimeri per ingegneria tissutale dell'osso 203
Evaluation of bone healing enhancement by lyophilized bone grafts supplemented with platelet gel: a standardized methodology in patients with tibial osteotomy for genu varus. 202
Diagnosis of infection after total hip replacement. 200
Applicazioni cliniche della ricerca ortopedica 198
La Chirurgia degli Organi di Movimento 191
Realizzazione in vitro in scaffolds compositi e poliuretanici colonizzati con cellule osteoprogenitrici umane isolate da pazienti con patologia ortopedica 190
Ability of restorative and fluoride releasing materials to prevent marginal dentine demineralization 190
Is wear debris responsible for failure in alumina-on-alumina implants? 189
Plasma levels of platelet-derived growth factor BB and transforming growth factor in patients with failed hip prostheses. 188
Biological basis for the use of autologous bone marrow stromal cells in the treatment of congenital pseudarthrosis of the tibia 187
FGF-2 effects on the osteogenic commitment of bone marrow stromal cells 185
Interferone-alfa come farmaco anti-osteolitico nel trattamento delle metastasi ossee da carcinoma renale 185
Bilateral total hip arthroplasty in Morquio-Brailsford's Syndrome: a report of two cases 185
Innesti ossei omologhi, gel di piastrine e cellule stromali concentrate autologhe: studio clinico randomatizzato 184
Increased osteoclast activity is associated with aggressiveness of osteosarcoma. 182
Molecular basis of osteoclastogenesis induced by osteoblasts exposed to wear particles 181
Le infezioni nelle artroprotesi di ginocchio 181
Histogenetic characterization of giant cell tumor of bone 181
In vitro blockade activator of nuclear factor-kappa B ligand prevents osteoclast differentiation induced by neuroblastoma cells 180
In vitro study of human osteoclast activity on poli(epsilon-caprolactone) as a bone substitute biomaterial 178
Metal ion release from fracture fixation devices: a potential marker of implant failure. 178
Ingegneria tissutale dell'osso: esperienze in vitro e in vivo con costrutti tridimensionali, superfici biomimetiche e fattori osteoriduttivi 176
Diagnosis of subclinical infection in orthopaedic joint implants 175
Cathepsin k antisense inhibition of cell polarization and bone resorption in human osteoclast 174
In vitro effects of an antisense oligonucleotide targeting fgf-2 on renal carcinoma cells metastasizing to bone 174
Primitive and bone metastatic renal carcinoma cells promote osteoclastogenesis through endothelial cells 174
Interferone-alfa come farmaco anti-osteolitico nel trattamento delle metastasi ossee da carcinoma renale 172
Poly-epsilon-caprolactone/hydroxyapatite composites for bone regeneration: in vitro characterization and human osteoblast response. 171
Evaluation of osteoblast-like cell response to Proroot™ MTA (mineral trioxide aggregate) cement 171
Effetti in vitro del gel di piastrine sulla proliferazione ed il differenziamento di cellule stromali del midollo osseo 169
Paracrine inhibition of osteoblast differentiation induced by neuroblastoma cells 169
The influence of alumina and ultra-high molecular weight polyethylene particles on osteoblast-osteoclast cooperation 169
Isolation, proliferation and differentiation of osteoblastic cells to study materials for bone engineering 168
Differences in ion release after ceramic-on-ceramic and metal-on-metal total hip replacement. Medium-term follow-up. 168
Molecular mechanism of osteolysis in advanced neuroblastoma 167
Bone healing enhancement by lyophilized bone grafts supplemented with platelet gel or platelet gel-bone marrow stromal cells in patients with high tibial osteotomy: a randomized study 167
serum level of osteoprotegerin (OPG) and 'receptor activator of nuclear factor ligand (RANKL) in patients with total hip prostheses 167
FENRETINIDE IS ACTIVE IN OSTEOSARCOMA IN VITRO BY INHIBITION OF CHOLESTEROL ESTERIFICATION 167
Elevated serum activity of TRACP5B in osteosarcoma patients (OS) is associated with an aggressive phenotype and with OS induced osteoclast activity 167
Serum levels of osteoprotegerin (OPG) and 'Receptor Activator of Nuclear Factor-k Ligand (RANKL)' in patients with hip prosthesis 166
In vitro effects of platelet rich plasma on bone marrow stromal cell differentiation 166
Bone Healing Enhancement By Lyophilized Bone Grafts Added with Platelet Gel or Platelet Gel–BMSCs in Patients with Tibial Osteotomy For Genu Varus 166
Isolation, characterisation and osteogenic potential of human bone marrow stromal cells derived from the medullary cavity of the femur 166
In vivo study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination. 166
Engineering bone by human osteogenic cells, biodegradabile scaffolds, and growth factors 164
Endothelial cells incubated with Platelet-Rich Plasma Express PDGF-B and ICAM-1 and induced bone marrow stromal cell migration. 164
Osteoclast expression of rank associated genes by osteoblast expose to alumina and uhmv particles 163
Toxicogenomics-based approach for studying the toxicity of metal ions 162
Ingegneria tissutale dell'osso: esperienze in vitro e in vivo con costrutti tridimensionali, superfici biomimetiche e fattori osteoinduttivi 161
Effects of activated platelet concentrates on human primary cultures of fibroblasts and osteoblasts 160
Bone with cement and antibiotic: antibiotic release in vitro 160
Diagnosis of infection after to replacement 159
Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis 159
In vitro characterization of human stromal cells from femoral marrow for bone engineering 159
Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma. 158
Histological reaction to ceramic wear in total hip arthroplasty (ceramic on ceramic compling) 157
In vitro effects of bone metastatic renal carcinoma cells on angiogenesis and bone resorption 156
Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. 156
Systemic cross-linked N-terminal telopeptide and procollagen I C-terminal extension peptide as markers of bone turnover after total hip arthroplasty. 154
Ingegneria tissutale dell'osso: esperienze in vitro e in vivo con costrutti tridimensionali, superfici biomimetiche e fattori osteoinduttivi 154
The potential role of metal ion release as a marker of loosening in patients with total knee replacement: a cohort study. 154
Serum markers of loosening in patients with THA 153
Height and pathogenesis of osteosarcoma 153
In vitro evaluation of freeze-dried bone allografts combined with platelet rich plasma and human bone marrow stromal cells for tissue engineering 153
MRI in diagnosis of osteoid osteoma of the proximal femur: a potentially deviating aspect. Description of a clinical case. 152
Role of IGF-IR in osteoclast biology and differentiation 152
Inibizione di fibroblast growth factor-2 (FGF-2) in linee cellulari di carcinoma renale, primitive e metastatiche, mediante oligonucleotide antisenso o anticorpo neutralizzante". 152
La chirurgia degli organi del movimento 152
Bone grafts with platelet gel and autologous stem cells:randomized study 152
La ricostruzione con cotile a stelo iliaco ed innesti ossei nelle gravi perdite di sostanza acetabolare 151
Osteogenic potential of bone marrow mesenchimal stem cells in congenital tibial pseudarthrosis associated with type I neurofibromatosis 151
experimental investigation on heterotopic ossification and fracture healing after brain injury 150
Pre-operative diagnosis of infection in total knee arthroplasty: an algorithm. 149
in vitro effects of interferon-alpha on different cellular elements existing in a bone metastasis of renal cell carcinoma 148
Stromal cells derived from giant cell tumor of bone show osteoblast-like feature 148
Two stage hip revision in periprosthetic infection: results of 41 cases. 148
Serum ion levels after ceramic-on-ceramic and metal-on-metal total hip arthroplasty: 8-year minimum follow-up 147
Immunogenic properties of renal cell carcinoma and the pathogenesis of osteolytic bone metastases. 146
Bone metastatic renal carcinoma cells enhance angiogenesis and osteoclast differentiation in vitro. 144
Rotula in trabecular metal nelle artroprotesi di ginocchio 143
Cytoskeletal disorganization in human osteoclasts following cathepsin K down-regulation 143
Ion release in stable hip arthroplasties using metal-on-metal bearings 142
Pathophysiology of periprosthetic osteolysis 141
Platelet gel accelerates bone repair process after tibial osteotomy: preliminary in vivo results 141
Fisiopatologia dell'osteolisi periprotesica 140
Immunogenic properties of renal cell carcinoma favour osteoclast recruitment in bone metastases 138
Potential role of tartrate-resistant acid phosphatase 5b (TRACP 5b) as a surrogate marker of late loosening in patients with total hip arthroplasty: A cohort study. 138
Knee arthrodesis with the Ilizarov external fixator as treatment for septic failure of knee arthroplasty. 136
Nuovi lembi nella chirurgia post-oncologica degli arti 134
Study on the in vitro effect of platelet rich plasma on bone endothelial cells and on osteoclast differentiation for maxillo-facial surgery 133
Elevated serum activity of TRACP5b in osteosarcoma patients is associated with an aggressive phenotype 133
Metal ion release from fracture fixation devices 132
Realizzazione in vitro in scaffolds compositi e poliuretanici colonizzati con cellule osteoprogenitrici umane isolate da pazienti con patologia ortopedica 129
Cytokeratin expression and prognosis of skeletal metastases 127
Totale 16.660
Categoria #
all - tutte 51.110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.110


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.105 0 0 168 241 174 135 34 134 53 275 421 470
2022/20232.447 327 351 126 281 227 162 68 121 399 34 234 117
2023/2024473 46 105 32 35 38 30 31 50 11 48 13 34
2024/20252.561 33 401 196 151 742 131 96 34 16 130 47 584
2025/20265.300 429 779 609 462 675 361 343 222 754 297 164 205
2026/2027858 97 177 584 0 0 0 0 0 0 0 0 0
Totale 20.095